Mr Dalvi Humzah

New toxin accepted for review

Biopharmaceutical company Hugel America and aesthetic manufacturer Croma-Pharma has unveiled that the US Food and Drug Administration (FDA) has approved the Biologics License Application (BLA) for letibotulinumtoxinA as a treatment for glabellar lines.

Read More »

DHAT launches business training

Dalvi Humzah Aesthetics Training (DHAT) will host a one-day business training agenda on January 21 to help newly qualified or soon to qualify aesthetic plastic surgeons get set up in private practice.

Read More »

Mr Dalvi Humzah elected as BMA representative

Aesthetics Media’s Clinical Advisory Board member and consultant plastic, reconstructive and aesthetic surgeon, Mr Dalvi Humzah, has been elected as one of two ‘private consultant or specialist clinical practice’ representatives for the British Medical Association’s (BMA) Private Practice Committee.

Read More »